Celldex Therapeutics Inc. (CLDX) Social Stream
CELLDEX THERAPEUTICS INC (CLDX) Price Targets From Analysts
Use the tables below to see what analysts covering CELLDEX THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-14 | 5 | $68 | $60 | $64.833 | $31.6 | 105.17% |
| 2022-03-01 | 6 | $68 | $60 | $64.833 | $31.6 | 105.17% |
| 2022-05-06 | 6 | $68 | $59 | $64.5 | $31.6 | 104.11% |
| 2022-08-09 | 5 | $73 | $59 | $66.8 | $31.6 | 111.39% |
| 2022-10-10 | 5 | $73 | $55 | $64.6 | $31.6 | 104.43% |
| 2023-02-27 | 6 | $73 | $55 | $64.333 | $31.6 | 103.59% |
| 2023-05-05 | 6 | $73 | $55 | $65 | $31.6 | 105.7% |
| 2023-08-09 | 6 | $73 | $54 | $64.833 | $31.6 | 105.17% |
| 2023-08-11 | 6 | $73 | $54 | $64.5 | $31.6 | 104.11% |
| 2023-10-19 | 7 | $73 | $21 | $58.285 | $31.6 | 84.45% |
| 2023-11-03 | 7 | $73 | $21 | $59.571 | $31.6 | 88.52% |
| 2023-11-04 | 7 | $73 | $21 | $59.285 | $31.6 | 87.61% |
| 2023-11-07 | 7 | $80 | $27 | $64 | $31.6 | 102.53% |
| 2023-11-13 | 7 | $80 | $27 | $63.285 | $31.6 | 100.27% |
The Trend in the Analyst Price Target
Over the past 37 weeks, CLDX's average price target has gone down $1.72.
CLDX reports an average of 94.6% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-22 | 6 | 73 | 55 | 65.000 | 36.31 | 79.01% |
| 2023-06-12 | 6 | 73 | 54 | 64.833 | 37.09 | 74.8% |
| 2023-08-09 | 6 | 73 | 54 | 64.833 | 30.52 | 112.43% |
| 2023-08-11 | 6 | 73 | 54 | 64.500 | 30.23 | 113.36% |
| 2023-08-22 | 7 | 73 | 21 | 58.285 | 28.98 | 101.12% |
CLDX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.57 | 6 | 0 | 0 | 1 | 1 | 7 |
The Trend in the Broker Recommendations
Over the past 26 weeks, CLDX's average broker recommendation rating worsened by 0.57.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, CELLDEX THERAPEUTICS INC's variance in analysts' estimates is lower than -652.06% of them.
- CLDX has a higher upside potential (average analyst target price relative to current price) than 1312.28% of all US stocks.
- In the context of Pharmaceutical Products stocks, CELLDEX THERAPEUTICS INC's average analyst price target is greater than 1300.61% of them.
- In the context of stocks in the mid market cap category, CELLDEX THERAPEUTICS INC's number of analysts covering the stock is greater than 567.33% of them.
Stocks similar to CELLDEX THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NEOG, EVO, and ZNTL.
View All Top Stocks by Price Target
Make investment decisions regarding CLDX using the data that counts. Try POWR Ratings for free.